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Abstract
Dengue virus (DENV) and Zika virus (ZIKV) are members of the Flaviviridae and are pre-
dominantly transmitted via mosquito bites. Both viruses are responsible for a growing num-
ber of infections in tropical and subtropical regions. DENV infection can cause lethargy with
severe morbidity and dengue shock syndrome leading to death in some cases. ZIKV is now
linked with Guillain-Barré syndrome and fetal malformations including microcephaly and
developmental disorders (congenital Zika syndrome). The protective and pathogenic roles
played by the immune response in these infections is unknown. Mucosal-associated invari-
ant T (MAIT) cells are a population of innate T cells with potent anti-bacterial activity. MAIT
cells have also been postulated to play a role in the immune response to viral infections. In
this study, we evaluated MAIT cell frequency, phenotype, and function in samples from sub-
jects with acute and convalescent DENV infection. We found that in acute DENV infection,
MAIT cells had elevated co-expression of the activation markers CD38 and HLA-DR and
had a poor IFNγ response following bacterial stimulation. Furthermore, we found that MAIT
cells can produce IFNγ in response to in vitro infection with ZIKV. This MAIT cell response
was independent of MR1, but dependent on IL-12 and IL-18. Our results suggest that MAIT
cells may play an important role in the immune response to Flavivirus infections.
Author summary
Dengue virus (DENV) and Zika virus (ZIKV) are responsible for a growing number of
infections in tropical and subtropical regions. DENV infection can cause dengue shock
syndrome leading to death in some cases, while ZIKV is now linked with Guillain-Barré
syndrome and congenital anomalies including microcephaly. The protective and
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pathogenic roles played by the immune response in these infection is unknown. Mucosal-
associated invariant T (MAIT) cells are a population of innate T cells with potent anti-bac-
terial activity. MAIT cells have also been postulated to play a role in the immune response
to viral infections. In this study, we found that MAIT cells are activated in acute DENV
infection and in vitro following ZIKV infection. MAIT cell IFNγ response to ZIKV infec-
tion was TCR independent, but IL-12 and IL-18 dependent. IFNγ produced from MAIT
cells could help limit viral replication. Further studies are needed to determine the protec-
tive or pathogenic role of MAIT cells in Flavivirus infections.
Introduction
Dengue virus (DENV) and Zika virus (ZIKV) are members of Flaviviridae and both are trans-
mitted mostly via mosquito bites. It is estimated that around 400 million people are infected
with DENV annually[1]. DENV infection symptoms range from mild disease, to dengue fever,
dengue hemorrhagic fever, and dengue shock syndromes, which can be fatal in some cases.
The mechanisms by which DENV infection causes severe illness are not completely under-
stood. An extensive immune activation, characterized by a cytokine storm, has been described
in DENV infection, and host factors are also likely to be involved[2]. Conventional antiviral
CD8+ T cells are activated and expanded following DENV infection[3], and have been pro-
posed to be protective by reducing the viral load[4].
Until recently, ZIKV had been understudied because the infection was thought to be associ-
ated only with a mild viral illness and of limited geographical distribution. In 2014, the virus
suddenly expanded its range dramatically and appeared in the Americas, leading to the most
widespread ZIKV outbreak in history. It is now estimated that over 2 billion people are living
in regions suitable for ZIKV transmission[5]. ZIKV infection is now linked with cases of Guil-
lain-Barré syndrome[6] and with a plethora of fetal malformations including microcephaly,
now called congenital Zika syndrome, following transmission from an infected pregnant
woman to her developing fetus[7]. The protective or pathogenic roles of T cells in ZIKV infec-
tion remains to be investigated.
Mucosal-associated invariant T (MAIT) cells are a population of innate T cells that repre-
sent 1–10% of T cells in the blood of healthy individuals[8]. They express a semi-invariant
TCR using Vα7.2 coupled with Jα33 and a limited Vβ repertoire[9]. A small fraction of MAIT
cells have been found to express Vα12 or Vα20[10]. Recent studies suggest that the TCR β-
chain has some influence on TCR dependent activation of MAIT cells[11, 12]. MAIT cells can
be identified by the expression of Vα7.2 in combination with CD161 or the IL-18 receptor[13].
They have been shown to recognize microbial vitamin B2 (riboflavin) metabolites presented
by the MHC class I-like protein MR1[14]. This allows MAIT cells to respond to a range of bac-
teria, mycobacteria, and yeasts[15]. MAIT cells can also be activated in a TCR independent
way by IL-12 and IL18[16], allowing them to respond to pathogens not producing riboflavin,
such as viruses[17, 18]. In chronic HIV-1 and HTLV-1 infections, MAIT cells are reduced in
number and display impaired functionality in response to bacterial stimulation[19–21]. A sim-
ilar MAIT cell impairement has been described in patients with chronic infections due to a pri-
mary immunodeficiency[22].
In this study, we investigated MAIT cells response in Flavivirus infection. We report that
MAIT cells are activated in acute DENV infection and have a poor response to in vitro bacte-
rial stimulation. We also report that MAIT cells can produce IFNγ in response to in vitro
ZIKV infection. This response was dependent on IL-12 and IL-18 and was impaired in HIV-
1-infected individuals.
MAIT cells in Flavivirus infection
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Materials and methods
Ethics statement
25 DENV-infected individuals from Sao Paulo, Brazil, were enrolled in the study (9 males and
16 females, age 17 to 87, Table 1). Patients were diagnosed with DENV infection by detection
of DENV NS1 antigen and/or IgM-specific antibodies using a commercially available rapid
test (Dengue Duo Test Bioeasy, Standard Diagnostic Inc. 575–34, Korea) or by detection of
DENV RNA by real time PCR (RT-PCR). Absolute cell counts were determined using an auto-
mated hematology analyzer (Abbott Cell-Dyn 3700 Hematology Analyzer) at the Hematology
Laboratory, Hematology Service, at the Faculty of Medicine, University of Sao Paulo. The
study was approved by the University of Sao Paulo institutional review board (CAPPesq), and
written informed consent was provided by all participants according to the Declaration of
Helsinki. Buffy coats from healthy donors were obtained from the New York Blood Bank as
approved by the George Washington University institutional review board. Samples from
HIV-1-infected patients were obtained from the Jacobi Medical Center (NY, USA) and written
informed consent was provided by all participants. This study was approved by Jacobi Medical
Center and the George Washington University institutional review boards. All samples from
all sites were anonymized. Minors were enrolled in the study, in which case legal guardians
provided written informed consent according to the Declaration of Helsinki.
Table 1. DENV patient demographics and cell count.
DENV subject Gender Age Leucocytes (cells/μL) Neutrophiles (cells/μL) Lymphocytes (cells/μL) Monocytes (cells/μL)
Acute Convalescent Acute Convalescent Acute Convalescent Acute Convalescent
1 M 28 3500 4800 1120 29820 1750 1200 460 380
2 F 25 2330 2300 700 3380 1170 2520 300 130
3 M 36 ND ND ND ND ND ND ND ND
4 M 36 4640 6470 1810 3170 1900 2650 460 580
5 M 30 3280 7060 1020 3530 1640 2540 390 490
6 F 41 4080 8430 1960 5050 1630 2440 450 590
7 F 28 4280 7460 2090 4700 1670 1940 430 600
8 F 31 5610 8850 3870 6990 1180 1240 450 620
9 F 33 6180 5910 3710 5820 1790 2030 250 700
10 F 38 2460 7750 950 2840 1230 2190 150 710
11 M 59 5930 5290 2190 3640 2610 2940 800 1010
12 F 63 4510 6700 500 2060 3340 2330 360 580
13 F 64 4909 5950 1350 3750 2540 1880 900 940
14 F 17 4260 7020 1830 2800 2000 2680 380 360
15 F 35 2450 7210 830 3090 980 3090 510 700
16 M 87 4880 11840 3270 4830 680 1370 930 940
17 F 17 5570 7150 2510 8290 2010 1780 1000 1070
18 M 21 7310 4020 5410 4360 800 2430 1100 290
19 F 63 3130 8000 2160 2060 310 2330 630 580
20 F 76 2480 5630 1530 2490 600 1170 320 320
21 F 36 2700 8030 1270 4240 920 3120 490 480
22 M 47 3820 5630 2410 2540 1150 2310 530 560
23 F 42 2710 8030 1080 5380 1270 2090 250 480
24 F 66 4110 9300 2670 5670 820 2980 580 470
25 M 40 4030 7940 1890 5960 1590 1590 480 240
ND: not determined. Normal range (cells/μl); Leukocytes: 4000–11000; Neutrophils 1600–7000; Lymphocytes: 900–3400; Monocytes 200–900.
https://doi.org/10.1371/journal.pntd.0006154.t001
MAIT cells in Flavivirus infection
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Sample collection
Peripheral blood mononuclear cells (PBMCs) were isolated by density-gradient sedimentation
using Ficoll-Paque (Lymphoprep, Nycomed Pharma, Oslo, Norway). Isolated PBMCs were
washed twice in Hank’s balanced salt solution (Gibco, Grand Island, NY), and cryopreserved
in RPMI 1640 (Gibco), supplemented with 20% heat inactivated fetal bovine serum (FBS;
Hyclone Laboratories, Logan UT), 50 U/ml of penicillin (Gibco), 50 μg/ml of streptomycin
(Gibco), 10 mM glutamine (Gibco) and 7.5% dimethylsulphoxide (DMSO; Sigma, St Louis,
MO). Cryopreserved cells from all subjects were stored in liquid nitrogen until used in the
assays. For DENV-infected patients, samples were collected during the acute phase of infection
(before defervescence) and 1 month after (convalescent phase). Plasma was collected by centri-
fugation and stored at -80˚C until used in the assays.
ZIKV stock preparation
Vero cells were obtained from the American Type Culture Collection (ATCC, Manassas, VA,
USA) and maintained using Eagle’s Minimum Essential Medium (ATCC) supplemented with
10% fetal bovine serum (FBS) at 37˚C with 5% CO2. ZIKV MR766 (ATCC) was added to Vero
cells at a MOI of 0.1 and incubated for 4–6 days. The supernatant was centrifuged at 12 000g
for 5 min, filtered (0.44 μm), aliquoted and stored at –80˚C. The viral titer was determined
using plaque assays on Vero cells as previously described[23]. Briefly, virus stocks were serially
diluted and adsorbed to confluent monolayers. After 1 h, the inoculum was removed and cells
were overlaid with semisolid medium containing 1% carboxymethyl cellulose (Sigma Aldrich,
St-Louis, MO, USA). Cells were further incubated for 5 days, fixed in 4% formaldehyde (Sigma
Aldrich), and stained with 1% crystal violet in 20% ethanol (Sigma Aldrich) for plaque visuali-
zation. Titers were expressed as plaque forming units (PFU) per milliliter. In some experi-
ments, ZIKV was heat inactivated by a 60 minutes incubation at 56˚C.
Flow cytometry and mAbs
Cryopreserved specimens were thawed and washed, and counts and viability were assessed
using the Countess Automated Cell Counter system (Invitrogen, Carlsbad, CA). Cells were
washed and stained in Brilliant Violet Stain Buffer (BD Biosciences, San Jose, CA) at room
temperature for 15 min in 96-well V-bottom plates in the dark. Samples were then washed and
fixed using Cytofix/Cytoperm (BD Biosciences) before flow cytometry data acquisition. Intra-
cellular staining was performed in Perm/Wash (BD Biosciences). mAbs used in flow cytome-
try: CD3 AF700, CD3 PerCP-Cy5.5 (both clone UCHT1), CD8 BV711 (clone RPA-T8), CD38
APC-H7 (clone HB7), CD127 FITC (clone HIL-7R-M2), CD161 BV421 (clone DX12), CCR6
BV786 (clone 11A9), HLA-DR APC (clone L243), IFNγ APC (clone B27), and PD-1 PE-Cy7
(clone EH12.1) were all from BD Biosciences, PLZF APC was from R&D Systems (Minneapo-
lis, MN), EOMES FITC (clone WD1928) was from eBioscience and TCR Vα7.2 PE (clone
3C10) was from Biolegend (San Diego, CA, USA). Live/dead aqua fixable cell stain was from
Life Technologies (Eugene, OR, USA). Data were acquired on a BD LSRFortessa instrument
(BD Biosciences) and analyzed using FlowJo Version 9.8.5 software (TreeStar, Ashland, OR,
USA).
Functional assay
MAIT cell function was determined in vitro using paraformaldehyde-fixed E. coli stimulation
(one shot top10, Life Technology, multiplicity of exposure 10) in the presence of 1.25 μg/ml
anti-CD28 mAb (clone L293, BD Biosciences)[24] or ZIKV at a MOI of 5 (without anti CD28
MAIT cells in Flavivirus infection
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mAb). E. coli was fixed for 5 minutes in 1% paraformaldehyde. PBMCs were further cultured
for 24 hours at 37˚C/5% CO2 in RPMI medium supplemented with 10% fetal bovin serum.
Monensin (Golgi Stop, BD Biosciences) was added during the last 6 hours of the stimulation.
In some experiments blocking antibodies against MR-1 (5μg/ml, clone 26.5, Biolegend), IL-
12p70 (10μg/ml, clone 24910, R&D systems), and IL-18 (10μg/ml, clone 125-2H, MBL Interna-
tional, Woburn, MA, USA) were added.
IL-7 and soluble CD14 (sCD14) measurement
IL-7 (RayBiotech, Norcross, GA, USA) and sCD14 (R&D Systems) were measured in plasma
by ELISA following manufacturer’s instruction.
Statistical analysis
All statistical analysis was performed using Graph Pad Prism version 6.0h for Mac OSX
(GraphPad Software, La Jolla, CA). The changes between acute and convalescent phases and
before/after ZIKV stimulation with or without blocking antibodies were analyzed with Wil-
coxon matched-pairs signed rank test. Associations between groups were determined by
Spearman’s rank correlation. P-values 0.05 were considered statistically significant.
Results
We enrolled 25 individuals with acute DENV infection, and we followed them during the con-
valescent phase (Table 1). We evaluated MAIT cell (defined as CD3+ CD161+ Vα7.2+, Fig 1A)
frequency by flow cytometry and found no significant difference between acute and conva-
lescent DENV infection (Fig 1B). However, MAIT cell counts were decreased in the acute
phase (Fig 1C) due to significant overall lymphopenia amongst infected patients (S1 Fig).
Next, we characterized the phenotype of MAIT cells in the acute and convalescent phases of
DENV infection. MAIT cells had significantly increased co-expression of the activation mark-
ers CD38 and HLA-DR (S1 Fig and Fig 1D), of the IL-7 receptor CD127 (S1 Fig and Fig 1E),
and of PD-1 (S1 Fig and Fig 1F) in the acute phase. We did not observe any difference in the
expression of CCR6 by MAIT between the acute and convalescent phases (Fig 1G). In chronic
viral infections MAIT cell activation is associated with their reduced frequency[19, 21]. Thus,
we investigated if there was an association between the reduced MAIT cell count in the acute
phase and their increased co-expression of CD38 and HLA-DR, and found a trend for an
inverse association (p = 0.0779, S1 Fig). Next, we compared the results for MAIT cells during
the convalescent phase to healthy controls from Brazil. We found that there was no difference
in the co-expression of CD38 and HLA-DR between the convalescent and healthy controls
individuals (S2 Fig). PD-1 remained elevated during the convalescent phase of DENV infec-
tion (S2 Fig) and CD127 was decreased compared to healthy controls (S2 Fig). Our results
show that MAIT cells are activated and reduced in number in acute DENV infection.
Because the majority of MAIT cells are CD8+, we evaluated the response of conventional
CD8 T cells in acute DENV infection. Conventional CD8 T cells had significantly elevated lev-
els of co-expression of CD38 and HLA-DR in the acute phase and the levels of co-expression
in the convalescent phase were similar to healthy controls (S3 Fig). PD-1 was also elevated on
CD8 T cell in the acute phase of infection. However, PD-1 levels in the convalescent phase
trend to remain elevated compared to healthy controls (S3 Fig). However, in contrast to MAIT
cells, the levels of CD127 on conventional CD8 T cells were not different between the acute
and the convalescent phase, or healthy controls (S3 Fig).
MAIT cells have been shown to have decreased expression of key transcription factors in
chronic viral infections[21, 25, 26]. Therefore, we investigated if MAIT cells showed a similar
MAIT cells in Flavivirus infection
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Fig 1. MAIT cells have elevated expression of activation markers in acute DENV infection. Gating strategy and representative flow
plots of MAIT cell frequency (A). MAIT cell frequency in acute and convalescent DENV infection (n = 25, B). MAIT cell count, (as
determined by multiplying the lymphocyte count by the frequency of MAIT cells in lymphocytes), in acute and convalescent DENV
infection (n = 24, C). Co-expression of CD38 and HLA-DR by MAIT cells in acute and convalescent DENV infection (n = 15, D).
CD127 expression (MFI) by MAIT cells in acute and convalescent DENV infection (n = 15, E). PD-1 expression by MAIT cells in
acute and convalescent DENV infection (n = 15, F). CCR6 expression (MFI) by MAIT cells in acute and convalescent DENV
infection (n = 15, G).  indicates p< 0.01, and  indicates p< 0.001.
https://doi.org/10.1371/journal.pntd.0006154.g001
MAIT cells in Flavivirus infection
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decrease of Eomes and PLZF expression in acute DENV infection. We found that Eomes
expression was reduced in convalescent DENV infection (Fig 2A and 2B) compared to the
acute phase and healthy controls. However, we did not observe any difference in PLZF expres-
sion between acute and convalescent DENV infection or healthy controls (Fig 2A and 2C).
Our results suggest that different transcription factor expression profiles are associated with
acute and chronic viral infections respectively.
Increased pro-inflammatory cytokines levels in DENV infection have been associated with
microbial translocation[27]. sCD14 is a marker of monocyte activation and is considered an
indirect marker of microbial translocation[28]. Thus, we measured the levels of sCD14 in our
cohort of DENV-infected subjects. Levels of sCD14 were significantly higher in the acute
Fig 2. Reduced Eomes expression by MAIT cells in convalescent DENV infection. Representative flow plots for
Eomes and PLZF expression by MAIT cells (A). Eomes (B) and PLZF (C) expression (MFI) by MAIT cells in acute and
convalescent DENV infection (n = 12) and healthy control (n = 6). The bars and whiskers represent the median and
interquartile range respectively.  indicates p< 0.05.
https://doi.org/10.1371/journal.pntd.0006154.g002
MAIT cells in Flavivirus infection
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phase of infection than in the convalescent phase (Fig 3A). Levels of sCD14 remained higher
in convalescent DENV compared to healthy controls. However, we did not find any significant
associations between the levels of sCD14 in acute DENV infection and co-expression of CD38
and HLA-DR by MAIT cells or with MAIT cell numbers (S4 Fig). Because we found elevated
expression of the IL-7 receptor by MAIT cells in acute DENV infection, we measured the levels
of plasma IL-7 in acute and convalescent DENV infection but did not find any significant
change (Fig 3B).
Next, to establish the functionality of MAIT cells, we investigated the in vitro response of
MAIT cells from the acute and convalescent phases of DENV infection to in vitro stimulation
with E. coli. There was no difference in IFNγ production by MAIT cells in the acute and conva-
lescent phases of DENV infection in the absence of stimulation (S5 Fig). MAIT cells in the
acute phase produced significantly less IFNγ after E. coli stimulation compared to the conva-
lescent phase (Fig 4A and 4B). The MAIT cell IFNγ response in the convalescent phase was
similar to the response of healthy controls (S5 Fig). Interestingly, we found that the levels of
sCD14 in acute DENV infection were inversely associated with the MAIT cell IFNγ response
(Fig 4C), possibly suggesting a role for monocyte activation in the poor MAIT cell response.
Finally, we used in vitro infection with ZIKV to study the mechanism of MAIT cell activa-
tion in a different Flavivirus infection. MAIT cells from healthy individuals consistently pro-
duced IFNγ in response to in vitro ZIKV infection (Fig 5A and 5B). In contrast to E. coli, the
MAIT cell IFNγ response to ZIKV could not be blocked by a MR-1 blocking antibody (Fig
5C). The IFNγ response from MAIT cells to ZIKV was partially reduced by blocking antibod-
ies against IL-12 and IL-18 and was completely blocked when they were used in combination
(Fig 5C). We also investigated if viral replication was needed for the MAIT cell response to in
vitro ZIKV infection. For this purpose, heat inactivated ZIKV was added to PBMCs and the
MAIT cell IFNγ response was compared to the response obtained using replication competent
ZIKV. We observed only a small reduction in IFNγ production by MAIT cells in response to
ZIKV when using a heat inactivated virus (Fig 5C), suggesting that viral replication is not
needed for production of IL-12 and IL-18 and subsequent MAIT cell activation.
Fig 3. Increased levels of sCD14 in acute DENV infection. Plasma levels of sCD14 (A) and IL-7 (B) in acute and
convalescent DENV infection were determined for subjects 1–10 (n = 10) and for healthy control (n = 5). The bars and
whiskers represent the median and interquartile range respectively.  indicates p< 0.01.
https://doi.org/10.1371/journal.pntd.0006154.g003
MAIT cells in Flavivirus infection
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Viral co-infections are common and understudied. In Brazil, many people living with HIV
will be exposed to dengue or zika viruses. MAIT cells from HIV-1-infected individuals exhibit
decreased functionality following stimulation with E. coli[19]. Thus, we evaluated the capacity
of MAIT cells from HIV-1-infected subjects (Table 2) to produce IFNγ in response to ZIKV
infection and found that in 5 out of 6 individuals there was no increase in IFNγ production in
response to ZIKV infection (Fig 5D). We then directly stimulated PBMCs with IL-12 and IL-
18 and found a similar IFNγ response by MAIT cells from HIV-1-infected and uninfected sub-
jects (Fig 5E), suggesting that MAIT cells from HIV-1-infected individuals have a normal
capacity to respond to cytokine stimulation.
Fig 4. Lower IFNγ production following in vitro stimulation with E. coli by MAIT cells in acute DENV infection.
MAIT cells were stimulated with fixed E. coli (multiplicity of exposure 10) for 24h and IFNγ production by MAIT cells
was evaluated by flow cytometry. Representative flow plots of IFNγ production by MAIT cells (A). IFNγ production by
MAIT cells in response to E. coli stimulation in acute and convalescent DENV infection (n = 15, B). Association
between the levels of sCD14 and MAIT cells IFNγ response to E. coli stimulation in acute DENV infection (C). 
indicates p< 0.05.
https://doi.org/10.1371/journal.pntd.0006154.g004
MAIT cells in Flavivirus infection
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Discussion
We found that MAIT cells are activated in acute human DENV infection as well as following
in vitro ZIKV infection. However, in contrast to a previous study[17], we did not find any sig-
nificant changes in MAIT cell frequency between acute and convalescent DENV infection.
Wilgenburg et al. focused on the study of CD8+ MAIT cells, while in this study, we also
Fig 5. MAIT cells response to in vitroZIKV infection is dependent on IL-12 and IL-18. PBMCs were infected with ZIKV (MOI: 5) for 24h and IFNγ
production by MAIT cells was evaluated by flow cytometry. Representative flow plots of IFNγ production by MAIT cells (A). MAIT cells IFNγ response to ZIKV
infection (n = 9, B). PBMCs were incubated in presence of MR1 (n = 6), IL-12 (n = 4), IL-18 (n = 8), and IL-12 + IL-18 (n = 4) blocking antibodies and
stimulated with E. coli, ZIKV, or heat inactivated ZIKV (n = 4) and IFNγ production by MAIT cells was measured (C). The results are presented as relative
production of IFNγ by MAIT cells compared to the condition without any blocking antibody. Statistical analysis was performed before data normalization.
PBMCs from HIV-1- (n = 8) and HIV-1+ (n = 6) subjects were infected with ZIKV (MOI: 5) and IFNγ production by MAIT cell was evaluated (D). PBMCs
from HIV-1- (n = 6) and HIV-1+ (n = 6) subjects were treated with IL-12 and IL-18 (both at 50ng/ml) for 24 hours and IFNγ production by MAIT cell was
evaluated (E). The bars and whiskers represent the median and interquartile range respectively.  indicates p< 0.05 and  indicates p< 0.01.
https://doi.org/10.1371/journal.pntd.0006154.g005
MAIT cells in Flavivirus infection
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included CD8- MAIT cells. In addition, the difference in timing of sample collection might
explain the differences between the two studies. We found that MAIT cell counts were
decreased in parallel with the total lymphocyte count during the acute phase. We found that
MAIT cells were activated during acute DENV infection, as had Wilgenburg and colleagues.
IL-12 and IL-18 have been shown to trigger MAIT cell activation[16], and monocyte produc-
tion of IL-18 is required for MAIT cell in vitro response to influenza A virus (IAV)[18]. The
levels of IL-12 and IL-18 are elevated in DENV infection[17, 29–31] and could therefore be
involved in MAIT cell activation, as shown here. We showed that MAIT cell IFNγ production
following in vitro ZIKV infection also depended on IL-12 and IL-18. Immune activation in
acute DENV infection has been associated with elevated levels of LPS and of markers of micro-
bial translocation[27, 32]. This raises the possibility that MAIT cells could also be activated in
a TCR-dependent way by microbial products during acute DENV. However, we did not find
an association between the levels of sCD14, an indirect marker of microbial translocation, and
MAIT cell activation in acute DENV. Rather, we found that sCD14 was inversely associated
with the in vitro IFNγ response of MAIT cells to E. coli. This suggests that monocyte activation
could result in poor antigen presentation to MAIT cells. An alternative explanation could be of
a temporary monocyte tolerance to stimulation induced by LPS. This could contribute to the
reduced MAIT cell response in the acute phase. Finally, the elevated expression of PD-1 on
MAIT cells during acute DENV infection could also contribute to the reduced IFNγ produc-
tion. Further studies are needed to confirm that both MAIT cells and monocytes are involved
in this defect.
Chronic viral infections have been associated with a reduced expression of the transcription
factors PLZF and Eomes by MAIT cells[21, 25, 26]. Interestingly, we found that DENV infec-
tion did not change the levels of PLZF expression in MAIT cells and their Eomes levels were
reduced in convalescent compared to acute DENV and healthy controls. CD56+ MAIT cells
have been shown to have a higher Eomes expression and a more robust response to IL-12 and
IL-18 than CD56- MAIT cells [11]. Therefore, it is possible that the decrease in Eomes expres-
sion by MAIT cells in convalescent DENV infection is part of a feedback loop to decrease their
response to cytokines. Another possibility is a decrease in the CD56+ subset of MAIT cells in
blood following acute DENV. We have also observed a decreased expression of the IL-7 recep-
tor (CD127) by MAIT cells during the convalescent phase. IL-7 has been shown to increase
MAIT cell response[26, 33]. Thus, reduced levels of Eomes and CD127 could by a mechanism
by which MAIT cells could prevent sustained activation following an acute infection.
Patients that recovered from IAV infection had higher circulating MAIT cells than those
that succumbed[18] and IFNγ production by MAIT cells has been shown to limit HCV repli-
cation in vitro[17]. Thus, there is increasing evidence that MAIT cells could play a protective
role in viral infections. DENV and ZIKV infections are associated with a range of clinical
symptoms. More studies are needed to investigate if MAIT cell frequency, functionality or acti-
vation status have an impact on the clinical outcome of DENV and ZIKV infections. In this
Table 2. HIV-1 patients demographics and characteristics.
HIV Subject Gender Age Treatment Comment
1 M 15.2 Yes
2 F 17.2 Yes Variable treatment adherence
3 F 17.8 Yes
4 M 26.8 Yes
5 M 25.0 No Non progressor
6 M 18.8 Yes
https://doi.org/10.1371/journal.pntd.0006154.t002
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regard, MAIT cell production of IFNγ could be part of an innate immune response to induce
an anti-viral state and compromise Flavivirus replication. Levels of serum IFNγ have been
reported to be inversely associated with DENV load and symptoms[34]. One limitation of our
study is that we focused only on peripheral MAIT cells. MAIT cells are present in the skin[35,
36] and skin resident MAIT cells may play a more important role in early innate defense fol-
lowing mosquito transmission of Flavivirus.
MAIT cells from HIV-1-infected individuals have been shown to have a lower production
of cytokines in response to E. coli stimulation[19]. In this study, we show that the cytokine
mediated MAIT cell response to in vitro viral infection is also impaired. However, MAIT
cells from HIV-1-infected subjects had a normal response to direct cytokine stimulation,
suggesting that poor IL-12 and IL-18 production in response to ZIKV infection could be
responsible for the impaired MAIT cell response in these individuals. This suggests that HIV-
1-infected individuals could have a poor innate immune response to ZIKV and be at a higher
risk to develop complications following Flavivirus infection. Case reports of HIV-1-infected
individuals with ZIKV infection have been reported[37, 38], including one case with congeni-
tal Zika syndrome[39]. Defective MAIT cell activation could be one factor contributing to the
increase incidence of severe dengue in HIV-1-infected subjects[40]. More studies are needed
to determine if MAIT cells contribute to protection or to immunopathology during Flavivirus
infections.
Overall, our results show that MAIT cells are activated in response to DENV and ZIKV
infections. This innate response was TCR-independent and defective in HIV-1-infected indi-
viduals. Further studies are necessary to determine the importance of MAIT cell responses in
the clinical outcomes of Flavivirus infections.
Supporting information
S1 Fig. Lymphocytes count in acute and convalescent DENV infection (n = 24, A). Represen-
tative flow plots of CD38 and HLA-DR co-expression by MAIT cells in acute and convalescent
DENV infection (B). CD127 expression level by MAIT cells in acute and convalescent DENV
infection (C). Representative flow plots of PD-1 expression by MAIT cells in acute and conva-
lescent DENV infection (D). Association between CD38 and HLA-DR co-expression and
MAIT cells count in acute DENV infection (E).
(TIFF)
S2 Fig. MAIT cell frequency in convalescent DENV infection (n = 25) and healthy controls
(n = 26), (A). Co-expression of CD38 and HLA-DR by MAIT cells in convalescent DENV
infection (n = 15) and healthy controls (n = 26), (B). PD-1 expression by MAIT cells in conva-
lescent DENV infection (n = 15) and healthy controls (n = 26), (C). CD127 expression (MFI)
by MAIT cells in convalescent DENV infection (n = 15) and healthy controls (n = 7), (D).
 indicates p< 0.05, and  indicates p< 0.01.
(TIFF)
S3 Fig. Co-expression of CD38 and HLA-DR by conventional CD8 T cells (excluding MAIT
cells) during acute and convalescent DENV infection (n = 10) and healthy controls (n = 23)
(A). PD-1 expression by conventional CD8 T cells in acute and convalescent DENV infection
(n = 10) and healthy controls (n = 23) (B). CD127 expression by convetional CD8 T cells in
acute and convalescent DENV infection (n = 10) and healthy controls (n = 5) (C). The bars
and whiskers represent the median and interquartile range, respectively.  indicates p< 0.05
and  indicates p< 0.01.
(TIFF)
MAIT cells in Flavivirus infection
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0006154 January 22, 2018 12 / 15
S4 Fig. Associations between sCD14 levels and co-expression of CD38 and HLA-DR by
MAIT cells (A) and MAIT cell count (B) in acute DENV infection.
(TIFF)
S5 Fig. Representative flow plots showing IFNγ production by unstimulated MAIT cells in
acute and convalescent dengue infection (A). IFNγ production by unstimulated MAIT cells in
acute and convalescent dengue infection (n = 12, B). IFNγ production by E. coli stimulated
MAIT cells in convalescent dengue infection (n = 15) and control subjects (n = 10) (C). The
bars and whiskers represent the median and interquartile range, respectively.
(TIFF)
Acknowledgments
The authors would like to thank all patients and healthy controls for their time and efforts
towards this study. We would like to thank Carla Alves for her support in the laboratory work.
Author Contributions
Conceptualization: Dominic Paquin-Proulx, Bianca A. N. Santos, Douglas F. Nixon, Esper G.
Kallas.
Formal analysis: Dominic Paquin-Proulx, Bianca A. N. Santos, Nathália Silveira Barsotti.
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Eduardo Levi, Michael G. Rosenberg.
Writing – original draft: Dominic Paquin-Proulx, Douglas F. Nixon, Esper G. Kallas.
Writing – review & editing: Vivian I. Avelino-Silva, Bianca A. N. Santos, Nathália Silveira
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